Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for HEPATITIS B SURFACE ANTIGEN

Ingredient

HEPATITIS B SURFACE ANTIGEN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RECOMBIVAX HB	40MCG	SOLUTION	Resolved	2018-06-13	2021-03-16	52350
RECOMBIVAX HB	10MCG	SOLUTION	Resolved	2018-03-19	2020-09-11	43284
RECOMBIVAX HB	10MCG	SOLUTION	Resolved	2017-09-26	2021-03-16	23503
RECOMBIVAX HB	10MCG	SOLUTION	Resolved	2017-07-12	2017-10-12	15524
RECOMBIVAX HB	10MCG	SOLUTION	Resolved	2017-03-13	2022-06-23	873
TWINRIX	720UNIT 20MCG	SUSPENSION	Resolved	2017-05-26	2017-07-19	11383
TWINRIX	720UNIT 20MCG	SUSPENSION	Resolved	2017-07-20	2017-12-06	16553
TWINRIX	720UNIT 20MCG	SUSPENSION	Resolved	2018-01-12	2018-01-19	35785
TWINRIX	720UNIT 20MCG	SUSPENSION	Resolved	2018-09-19	2019-03-15	62029
TWINRIX	720UNIT 20MCG	SUSPENSION	Resolved	2019-05-03	2019-10-22	83033

Showing 21 to 30 of 36

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Discontinued	2019-12-10	2020-05-27	100904
ENGERIX-B	10MCG	SUSPENSION	Discontinued	2019-12-10	2020-04-30	100907
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281666
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Discontinued	2026-03-27	2026-04-18	281670
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281676

1

Showing 1 to 5 of 5